Daniel Woolson - 15 Mar 2026 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Reporting relationship: VP, GM-Infusion Capital
Issuer ticker: ICUI
Reported as of: 15 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Mar 2026, 16:33:55 UTC
Prior SEC filing: 09 Mar 2026
Next SEC filing: 22 May 2026
Source filing: View source filing
Reporting owner signature: By: Paula Darbyshire, Attorney-in-Fact For: Daniel Woolson

Key filing fact

Daniel Woolson filed Form 4 for ICU MEDICAL INC/DE (ICUI) on 16 Mar 2026.

Key facts

This page summarizes Daniel Woolson's Form 4 filing for ICU MEDICAL INC/DE (ICUI).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Mar 2026, 16:33.

Change

Previous filing in this sequence was filed on 09 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698998 Primary reporting owner

Woolson Daniel

Relationship: VP, GM-Infusion Capital
Address: 951 CALLE AMANECER, SAN CLEMENTE
Signature: By: Paula Darbyshire, Attorney-in-Fact For: Daniel Woolson
Signature date: 16 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICUI transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,924
Change %: +13%
Price: $0.000000^*
Shares after: 25,897
Date: 15 Mar 2026
Ownership: Direct
Footnotes: F1

ICUI transaction

Common Stock

Tax liability

Transaction value
Shares: -1,295
Change %: -5%
Price: $125.85^*
Shares after: 24,602
Date: 15 Mar 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ICUI transaction Derivative

Performance Shares

Options Exercise

Transaction value
Shares: -2,924
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 15 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,924
Exercise price: $0.000000
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These Securities are Performance-based Restricted Stock Units (PRSU).

Footnote F2

There is neither a purchase price nor an exercise price for the PRSUs.

Footnote F3

These PRSUs were granted on May 17, 2023. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 15 of the first, second, and third year following the year of grant.